D-alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing

Journal of Bacteriology

Volumn 195, Issue 22, 2013, Pages 5102-5111

  Taneja, Neetu Kumra ^a   Ganguly, Tridib ^a   Bakaletz, Lauren O ^b   Nelson, Kimberly J ^a   Dubey, Purnima ^a   Poole, Leslie B ^a   Deora, Rajendar ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CATION; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; PROTEINASE K;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CELL SURFACE; GENE LOCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNITY; LEUKOCYTE; NONHUMAN; OPERON; OUTER MEMBRANE; PHAGOCYTE; PRIORITY JOURNAL;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA PERTUSSIS; CELLS, CULTURED; DRUG RESISTANCE, BACTERIAL; ENDOPEPTIDASE K; GENETIC LOCI; HUMANS; NEUTROPHILS; PROTEOLYSIS;

EID: 84887227944     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00510-13     Document Type: Article

References (62)

1. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382.
2. Centers for Disease Control and Prevention. 2002. Pertussis-United States, 1997-2000. JAMA 287:977-979.
3. Centers for Disease Control and Prevention. 2012. Pertussis epidemic-Washington, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:517-522.
4. Mooi FR. 2010. Bordetella pertussis and vaccination:the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 10:36-49.
5. McNabb SJ, Jajosky RA, Hall-Baker PA, Adams DA, Sharp P, Anderson WJ, Javier AJ, Jones GJ, Nitschke DA, Worshams CA, Richard RA, Jr. 2007. Summary of notifiable diseases-United States, 2005. MMWR Morb. Mortal. Wkly. Rep. 54:1-92.
6. Yeh SH, Mink CM. 2006. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults? Drugs 66:731-741.
7. Gilberg S, Njamkepo E, Du Chatelet IP, Partouche H, Gueirard P, Ghasarossian C, Schlumberger M, Guiso N. 2002. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186:415-418.
8. de GreeffSC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. 2010. Pertussis disease burden in the household:how to protect young infants. Clin. Infect. Dis. 50:1339-1345.
9. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Munoz-Rivas F, Teyssou R, Guiso N, Van Rie A. 2007. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26:293-299.
10. Lai Y, Gallo RL. 2009. AMPed up immunity:how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30:131-141.
11. Ganz T. 2004. Antimicrobial polypeptides. J. Leukoc. Biol. 75:34-38.
12. Nizet V. 2006. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 8:11-26.
13. Brogden KA, Ackermann M, McCray PB, Jr, Tack BF. 2003. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents 22:465-478.
14. Hancock RE, Scott MG. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U.S.A. 97:8856-8861.
15. Melo MN, Ferre R, Castanho MA. 2009. Antimicrobial peptides:linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 7:245-250.
16. Elahi S, Buchanan RM, Attah-Poku S, Townsend HG, Babiuk LA, Gerdts V. 2006. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect. Immun. 74: 2338-2352.
17. Fernandez RC, Weiss AA. 1996. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrob. Agents Chemother. 40: 1041-1043.
18. Banemann A, Deppisch H, Gross R. 1998. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect. Immun. 66:5607-5612.
19. Noofeli M, Bokhari H, Blackburn P, Roberts M, Coote JG, Parton R. 2011. BapC autotransporter protein is a virulence determinant of Bordetella pertussis. Microb. Pathog. 51:169-177.
20. Peschel A, Sahl HG. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
21. Stainer DW, Scholte MJ. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
22. Conover MS, Mishra M, Deora R. 2011. Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PLoS One 6:e16861. doi:10.1371/journal.pone.0016861.
23. Deora R. 2002. Differential regulation of the Bordetella bipA gene:distinct roles for different BvgA binding sites. J. Bacteriol. 184:6942-6951.
24. Miller VL, Mekalanos JJ. 1988. A novel suicide vector and its use in construction of insertion mutations:osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
25. Brickman TJ, Cummings CA, Liew SY, Relman DA, Armstrong SK. 2011. Transcriptional profiling of the iron starvation response in Bordetella pertussis provides new insights into siderophore utilization and virulence gene expression. J. Bacteriol. 193:4798-4812.
26. Kovach ME, Phillips RW, Elzer PH, Roop RM, 2nd, Peterson KM. 1994. pBBR1MCS:a broad-host-range cloning vector. Biotechniques 16:800-802.
27. Chevion M, Panos C, Linzer R, Neuhaus FC. 1974. Incorporation of D-alanine into the membrane of Streptococcus pyogenes and its stabilized L-form. J. Bacteriol. 120:1026-1032.
28. Sukumar N, Mishra M, Sloan GP, Ogi T, Deora R. 2007. Differential Bvg phase-dependent regulation and combinatorial role in pathogenesis of two Bordetella paralogs, BipA and BcfA. J. Bacteriol. 189:3695-3704.
29. Rosenthal RS, Dziarski R. 1994. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 235:253-285.
30. Folkening WJ, Nogami W, Martin SA, Rosenthal RS. 1987. Structure of Bordetella pertussis peptidoglycan. J. Bacteriol. 169:4223-4227.
31. Tuomanen E, Schwartz J, Sande S, Light K, Gage D. 1989. Unusual composition of peptidoglycan in Bordetella pertussis. J. Biol. Chem. 264: 11093-11098.
32. Abi Khattar Z, Rejasse A, Destoumieux-Garzon D, Escoubas JM, Sanchis V, Lereclus D, Givaudan A, Kallassy M, Nielsen-Leroux C, Gaudriault S. 2009. The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects. J. Bacteriol. 191:7063-7073.
33. Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A, Holst O, Huebner J. 2006. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74:4164-4171.
34. Cox KH, Ruiz-Bustos E, Courtney HS, Dale JB, Pence MA, Nizet V, Aziz RK, Gerling I, Price SM, Hasty DL. 2009. Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One 4:e5366. doi:10.1371/journal.pone.0005366.
35. Kristian SA, Lauth X, Nizet V, Goetz F, Neumeister B, Peschel A, Landmann R. 2003. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188:414-423.
36. McBride SM, Sonenshein AL. 2011. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 157:1457-1465.
37. Neuhaus FC, Heaton MP, Debabov DV, Zhang Q. 1996. The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. Microb. Drug Resist. 2:77-84.
38. Palumbo E, Deghorain M, Cocconcelli PS, Kleerebezem M, Geyer A, Hartung T, Morath S, Hols P. 2006. D-Alanyl ester depletion of teichoic acids in Lactobacillus plantarum results in a major modification of lipoteichoic acid composition and cell wall perforations at the septum mediated by the Acm2 autolysin. J. Bacteriol. 188:3709-3715.
39. Ganz T. 2003. Defensins:antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720.
40. Selsted ME, Ouellette AJ. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
41. Bingle CD, Craven CJ. 2002. PLUNC:a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11:937-943.
42. Sayeed S, Nistico L, St Croix C, Di YP. 2013. Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect. Immun. 81:285-291.
43. McGillivary G, Bakaletz LO. 2010. The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway. PLoS One 5:e13224. doi:10.1371/journal.pone.0013224.
44. Li X, Li Y, Han H, Miller DW, Wang G. 2006. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128:5776-5785.
45. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77: 451-459.
46. Friedrich C, Scott MG, Karunaratne N, Yan H, Hancock RE. 1999. Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob. Agents Chemother. 43:1542-1548.
47. Kraus D, Herbert S, Kristian SA, Khosravi A, Nizet V, Gotz F, Peschel A. 2008. The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol. 8:85. doi:10.1186/1471-2180-8-85.
48. Cederlund A, Gudmundsson GH, Agerberth B. 2011. Antimicrobial peptides important in innate immunity. FEBS J. 278:3942-3951.
49. Darveau RP, Hancock RE. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838.
50. Harvill ET, Cotter PA, Miller JF. 1999. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection. Infect. Immun. 67:6109-6118.
51. Boyd DA, Cvitkovitch DG, Bleiweis AS, Kiriukhin MY, Debabov DV, Neuhaus FC, Hamilton IR. 2000. Defects in D-alanyl-lipoteichoic acid synthesis in Streptococcus mutans results in acid sensitivity. J. Bacteriol. 182:6055-6065.
52. Clemans DL, Kolenbrander PE, Debabov DV, Zhang Q, Lunsford RD, Sakone H, Whittaker CJ, Heaton MP, Neuhaus FC. 1999. Insertional inactivation of genes responsible for the D-alanylation of lipoteichoic acid in Streptococcus gordonii DL1 (Challis) affects intrageneric coaggregations. Infect. Immun. 67:2464-2474.
53. Sebaihia M, Preston A, Maskell DJ, Kuzmiak H, Connell TD, King ND, OrndorffPE, Miyamoto DM, Thomson NR, Harris D, Goble A, Lord A, Murphy L, Quail MA, Rutter S, Squares R, Squares S, Woodward J, Parkhill J, Temple LM. 2006. Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis, and B. parapertussis reveals extensive diversity in surface structures associated with host interaction. J. Bacteriol. 188:6002-6015.
54. Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. 1996. Achromobacter xylosoxidans bacteremia:report of four cases and review of the literature. Clin. Infect. Dis. 23:569-576.
55. Mansfield J, Genin S, Magori S, Citovsky V, Sriariyanum M, Ronald P, Dow M, Verdier V, Beer SV, Machado MA, Toth I, Salmond G, Foster GD. 2012. Top 10 plant pathogenic bacteria in molecular plant pathology. Mol. Plant Pathol. 13:614-629.
56. Costechareyre D, Chich JF, Strub JM, Rahbe Y, Condemine G. 2013. Transcriptome of Dickeya dadantii infecting Acyrthosiphon pisum reveals a strong defense against antimicrobial peptides. PLoS One 8:e54118. doi:10.1371/journal.pone.0054118.
57. Richet H. 2012. Seasonality in Gram-negative and healthcare-associated infections. Clin. Microbiol. Infect. 18:934-940.
58. Hankins JV, Madsen JA, Giles DK, Brodbelt JS, Trent MS. 2012. Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc. Natl. Acad. Sci. U.S.A. 109:8722-8727.
59. Scheffers DJ, Pinho MG. 2005. Bacterial cell wall synthesis:new insights from localization studies. Microbiol. Mol. Biol. Rev. 69:585-607.
60. CaroffM, Brisson J, Martin A, Karibian D. 2000. Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett. 477:8-14.
61. Clark VL, Young FE. 1978. D-Alanine incorporation into macromolecules and effects of D-alanine deprivation on active transport in Bacillus subtilis. J. Bacteriol. 133:1339-1350.
62. Kolter R, Inuzuka M, Helinski DR. 1978. Trans-complementationdependent replication of a low molecular weight origin fragment from plasmid R6K. Cell 15:1199-1208.